HomeMBIO • CNSX
add
MindBio Therapeutics Corp
Previous close
$1.40
Year range
$0.20 - $3.99
Market cap
6.69M CAD
Avg Volume
2.92K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.20M | 1,622.02% |
Net income | -1.21M | -2,536.18% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.20M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 21.80K | -56.69% |
Total assets | 73.92K | -31.82% |
Total liabilities | 2.56M | -56.67% |
Total equity | -2.48M | — |
Shares outstanding | 2.04M | — |
Price to book | -0.99 | — |
Return on assets | -3,163.58% | — |
Return on capital | 1,356.10% | — |
Cash Flow
Net change in cash
| (AUD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.21M | -2,536.18% |
Cash from operations | -42.24K | 47.44% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -42.24K | 52.20% |
Free cash flow | 414.13K | 51.84% |
About
Founded
2021
Headquarters
Website
Employees
70
